JPMORGAN CHASE & CO - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$116
-60.0%
1,300
-58.8%
0.00%
Q2 2023$2903,152
+142.5%
0.00%
Q1 2023$01,3000.0%0.00%
Q4 2022$01,300
+23.8%
0.00%
Q3 2022$0
-100.0%
1,0500.0%0.00%
Q2 2022$1,0000.0%1,0500.0%0.00%
Q1 2022$1,0000.0%1,0500.0%0.00%
Q4 2021$1,000
-50.0%
1,0500.0%0.00%
Q3 2021$2,0000.0%1,0500.0%0.00%
Q2 2021$2,000
-33.3%
1,050
-19.2%
0.00%
Q1 2021$3,0000.0%1,3000.0%0.00%
Q4 2020$3,000
-25.0%
1,3000.0%0.00%
Q3 2020$4,000
-33.3%
1,300
-10.3%
0.00%
Q2 2020$6,000
+500.0%
1,450
+11.5%
0.00%
Q1 2020$1,000
-88.9%
1,300
-82.1%
0.00%
Q4 2019$9,000
+800.0%
7,255
+458.1%
0.00%
Q3 2019$1,0000.0%1,3000.0%0.00%
Q2 2019$1,0001,3000.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Allred Capital Management, LLC 466,688$41,8620.02%
Warberg Asset Management LLC 194,997$17,4910.00%
Virtu Financial LLC 333,069$300.00%
UBS Group AG 149,612$13,4660.00%
NewEdge Advisors, LLC 412$360.00%
Parallel Advisors, LLC 350$310.00%
BANK OF AMERICA CORP /DE/ 1,604$1430.00%
WELLS FARGO & COMPANY/MN 5,632$5040.00%
NORTHERN TRUST CORP 39,414$3,5350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders